Our Team

Skerdi Haviari

Skerdi Haviari

Scientific director

Skerdi joined Seventure Partners Life sciences team in May, 2019.

A physician-scientist by training, specialized in clinical pharmacology, he began his career at the Hospices Civils de Lyon teaching hospital working on epidemiology, biostatistics, pharmacology and proof-of-concept clinical trial design in oncology. There, he led research projects and authored first-tier academic publications in diverse fields such as infection control (EID), machine learning on hospital data (JAMA and BMJ Q&S), and clinical trial size reduction with improved therapeutic strategies (Cancer Research). He then took two leaves of absence, one to join the French branch of the EMA (ANSM) as a pre-clinical and clinical assessor for phase I trial authorizations (all indications) and oncology evaluations (all stages), and the other to conduct clinical and medico-economic analyses in Eli Lilly’s market access and new product planning department.

An alumnus of Ecole Normale Supérieure Paris, where he obtained an MSc in systems biology, Skerdi holds an MD from Université Lyon Claude Bernard, a board certification in public health, and an MBA from Collège des Ingénieurs.

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse